Close
Nordic 9Nordic 9

Novartis Venture Fund (investor - Corporate Investor)

Switzerland nvfund.com
See something wrong or missing? Let us know
Offices:Basel

Novartis Venture Funds is a private equity and venture capital arm of Novartis AG specializing in stage agnostic investments (seed to commercial companies)  in Biotechnology/Biopharma life sciences companies from multiple therapeutic areas where there is clear unmet medical need.

Average round investment:53.62M USD
Average number per year:2.9
Distribution: 2025 (3)2024 (5)2023 (3)2022 (4)2021 (4) See the entire list
Portfolio companies: United Kingdom NRG TherapeuticsSpain Splice BioSwitzerland Granite Bio See the entire list
Mostly invests in: United Kingdom United Kingdom (7) Health services (22)
See the entire list

Showing 3 of 23 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Novartis Venture Fund mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Novartis Venture Fund

Name Criteria
Ireland Seroba Life Sciences
92%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma, Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom, Germany, Netherlands, Ireland
  • Average number of deals per year: 2.6
  • Active last 12 months: Yes
United States Invus
91%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma, Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom, Switzerland, Finland
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
Italy Novacapital
91%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom, Switzerland
  • Average number of deals per year: 3.5
  • Active last 12 months: Yes
Germany Porsche Ventures
91%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom, Switzerland, Germany
  • Average number of deals per year: 3.6
  • Active last 12 months: Yes
Spain Asabys Partners
91%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma, Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: Germany, Spain
  • Average number of deals per year: 3.9
  • Active last 12 months: Yes
France Eiffel Investment Group
91%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Manufacturing, Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: Germany, Spain
  • Average number of deals per year: 3.9
  • Active last 12 months: Yes
Germany Boehringer Ingelheim Venture Fund
91%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma, Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom, Switzerland, Germany
  • Average number of deals per year: 3.9
  • Active last 12 months: Yes
Israel Canaan Partners
91%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma, Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom, Germany
  • Average number of deals per year: 3.9
  • Active last 12 months: Yes
Spain Kibo Ventures
91%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom, Germany, Spain
  • Average number of deals per year: 3.9
  • Active last 12 months: Yes
United States Endeavor Catalyst
91%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Manufacturing, Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom, Germany, Spain, Ireland
  • Average number of deals per year: 4.0
  • Active last 12 months: Yes
Top